:

Yu Saida1, Satoshi Watanabe1, Toshiaki Kikuchi1

  • 1Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

PubMed
概括

小细胞肺癌 (SCLC) 治疗正在超越化疗. 了解SCLC分子亚型和生物标志物可能会提高广泛阶段疾病的免疫疗法的有效性.